Professor Emeritus Lloyd Samson AO retires from Bellberry’s Board

The Founding Chair of Bellberry’s Board of Directors, Fraser Bell, has paid tribute to retiring Board member Professor Emeritus Lloyd Sansom AO for his 12 years on the Board.

“Once in a while a Board gets to work with a person of enormous integrity, wisdom, humility, humour and a capacity to roll up his sleeves and get things done,” said Mr Bell.

“Bellberry has had just that opportunity with Lloyd Sansom. Our company made huge strides forward due to Lloyd's vision with our Thought Leadership Program in particular.

“While that is the obvious legacy, each of his fellow Board members and the executive team are better off for having shared the journey with Lloyd,” said Mr Bell.

Professor Sansom was Professor of Pharmacy as well as Head of the School of Pharmacy and Medical Sciences at the University of South Australia. In 2004 his contribution to the University was recognised with the naming of the Sansom Institute for Health Research.

He was also the Chair of the Australian Pharmaceutical Advisory Council from 1991-2000 and Chair of the Pharmaceutical Benefits Advisory Committee from 2001 to 2012.

Professor Sansom said it’s been a privilege to watch Bellberry grow over the last 12 years.

“Bellberry is a company that provides a high-quality service, but it does more than that. It is contributing to the advancement of the discipline of clinical trial research in this country and beyond,” said Professor Sansom.

Professor Andrew Wilson AO, who has recently retired as chair of the Pharmaceutical Benefits Advisory Committee will be joining the Bellberry Board.

Board Chair Fraser Bell has welcomed Professor Wilson’ appointment, “Andrew’s expertise and insights are well known to us and we are looking forward to working with him”.

Bellberry is Australia’s largest reviewer of human research reviewing more than 40% of CTN Clinical Trials in Australia. It’s a national, independent, not-for-profit organsiation focused on improving the welfare of human research participants and the quality, efficiency and effectiveness of medical research through its HREC reviews and philanthropic activities.

For media queries contact alisonrogers@bellberry.com.au or call 0488 995 868

[caption id="attachment_5392" align="alignnone" width="400"] Professor Emeritus Lloyd Sansom AO[/caption]

Share this article:

Other articles

A blog for the latest news and articles related to the ethical review of human research from Bellberry Limited.

View all articles
Apr 30, 2026

Impact Report 2025

We’re proud to share Bellberry’s 2025 Impact Report - our first report bringing together key insights, data and achievements from the past…

Read More
Mar 25, 2026

Bellberry Office Easter Closure 2026

The Bellberry office will be closed for the Easter break on Friday 3 April and Monday 6 April. Reopening at 9am on…

Read More
Feb 17, 2026

2026 Podcast Season: More About NAMs

When a potential new medicine is tested on humans for the first time it is a milestone. It is thoroughly tested for…

Read More
Dec 23, 2025

Bellberry Newsletter – Summer 2025

Welcome to our newsletter for summer 2025. The Bell contains a roundup of the activities Bellberry has been involved with in the…

Read More
Dec 1, 2025

2025-26 Meeting & Submission Dates

Our end of year meeting and submission dates are as follows: The Bellberry office will be closed from COB Wed 24 December…

Read More
Dec 1, 2025

Project Officer Vacancy

Project Officer - Adelaide, Full time We're seeking a Project Officer with strong auditing and governance experience to help deliver services that…

Read More
Nov 12, 2025

2025/26 Bellberry-Viertel Fellow Announced

Last month at the Australian Academy of Health and Medical Sciences Gala Dinner in Canberra our new Bellberry-Viertel Fellow was announced! Congratulations…

Read More
Oct 30, 2025

2025-26 Meeting & Submission Dates

Our end of year meeting and submission dates are as follows: The Bellberry office will be closed from COB Wed 24 December…

Read More
Sep 30, 2025

National Statement Updates 2025

The National Statement on Ethical Conduct in Human Research is the principal reference for research involving humans in Australia and is the…

Read More
Sep 30, 2025

Operations Update 28

In the September issue of our Operations Update please find articles on: New Bellberry office address New eProtocol registrations contact email Bellberry…

Read More
Sep 30, 2025

Bellberry User Satisfaction Survey

As Australia’s largest provider of Human Research Ethics Committee services, Bellberry places great value on understanding the experience our users have of…

Read More
Sep 30, 2025

International Research Administrators Day

Today, September 25, we celebrate International Research Administrators Day! This globally recognised day honours the contribution of Research Administrators in supporting and…

Read More
Jun 12, 2025

NAMs workshop summary report released

We are pleased to release the summary report from the Bellberry & ASCEPT New Approach Methodologies (NAMs) Introductory Workshop, held in Melbourne,…

Read More
May 21, 2025

ACTA Trial of the Year Award Winner

On May 20, 2025, the Australian Clinical Trials Alliance (ACTA) hosted its annual Trial of the Year Awards, coinciding with International Clinical…

Read More
May 21, 2025

Clinical Trial Activity Report (CTAR) 2024

Report highlights international confidence in Australian clinical trials Global investment in Australian clinical trials is strong, with two thirds of Australian clinical…

Read More